Login to Your Account



Clinic Roundup


Tuesday, May 17, 2011
Pacira Pharmaceuticals Inc., of Parsippany, N.J., said that its Phase III trial of Exparel for pain control post-hemorrhoidectomy met its primary endpoint of reducing pain and opioid use in the first 72 hours. Results were presented in a poster at the 2011 American Society of Colon and Rectal Surgeons annual meeting in Vancouver, British Columbia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription